GENETICAL ASPECTS OF SURGICAL TREATMENT IN PATIENTS WITH HEREDITARY BREAST CANCER

GENETICAL ASPECTS OF SURGICAL TREATMENT IN PATIENTS WITH HEREDITARY BREAST CANCER

Numerous available results of investigations confirmed the important role of prophylactic bilateral laparoscopic salpingo-oophorectomy and contralateral prophylactic subcutaneous mastectomy in decrease of risks of malignant tumors of the reproductive system when mutation carriers of BRCA1 and BRCA2...

Full description

Bibliographic Details
Main Author:	E. M. Bit-Sava
Format:	Article
Language:	Russian
Published:	Pavlov First Saint Petersburg State Medical University 2018-01-01
Series:	Вестник хирургии имени И.И. Грекова
Subjects:	наследственный рак молочной железы профилактическая контралатеральная мастэктомия профилактическая билатеральная сальпингоофорэктомия hereditary breast cancer prophylactic contralateral mastectomy prophylactic bilateral salpingo-oophorectomy
Online Access:	https://www.vestnik-grekova.ru/jour/article/view/574

Similar Items

Some clinical morphological and molecular genetic aspects in patients with clinical signs of hereditary breast cancer
by: Yu S Shatova, et al.
Published: (2018-04-01)

Odnomomentnye mastektomii i laparoskopicheskie ovariektomii v lechenii raka molochnoy zhelezy
by: R A Khvastunov, et al.
Published: (2007-09-01)

Occurrence of BRCA1 and BRCA2 mutation in pancreatic cancer patients
by: A. A. Kashintsev, et al.
Published: (2016-02-01)

Contemporary view to prophylactic salpingectomy
by: A. A. Popov, et al.
Published: (2015-04-01)

Hereditary breast cancer: present status of problem
by: F. S. Gatueva, et al.
Published: (2020-05-01)

CONTRALATERAL PROPHYLACTIC MASTECTOMY AND SIMULTANEOUS BREAST RECONSTRUCTION WITH IMPLANTS AFTER ONE SIDED BREAST CANCER: ANALYSIS OF 12 CASES IN CONTEXT OF THE CURRENT TRENDS
by: Roman Romansky, et al.
Published: (2016-08-01)

Legal Aspects of Bilateral Mastectomies for Patients With or Without Mutated Genes
by: Remy Salmon
Published: (2018-06-01)

Efetividade da salpingo-ooforectomia redutora de risco na prevenção de neoplasias ginecológicas em uma população franco-canadense com risco elevado
by: Bacha, Omar Moreira
Published: (2012)

Efetividade da salpingo-ooforectomia redutora de risco na prevenção de neoplasias ginecológicas em uma população franco-canadense com risco elevado
by: Bacha, Omar Moreira
Published: (2012)

Efetividade da salpingo-ooforectomia redutora de risco na prevenção de neoplasias ginecológicas em uma população franco-canadense com risco elevado
by: Bacha, Omar Moreira
Published: (2012)

Hereditary breast cancer: genetic and clinical hetergeneity, genetic testing, prophylactic surgery
by: L. N. Lyubchenko, et al.
Published: (2015-06-01)

Vliyanie rekonstruktivno-plasticheskikh operatsiy na kachestvo zhizni bol'nykh rakom molochnoy zhelezy v otdalennom periode
by: Kh S Arslanov, et al.
Published: (2006-12-01)

Association between unilateral or bilateral mastectomy and breast cancer death in patients with unilateral ductal carcinoma
by: Agarwal S, et al.
Published: (2017-11-01)

Tayverb/Tyverb (lapatinib) – pervyy dvoynoy anti-ErbB1(EGFR)i anti-ErbB2(HER2)-ingibitor v lechenii mestno-rasprostranennogo i metastaticheskogo raka molochnoy zhelezy zaregistrirovan v Rossiyskoy Federatsii
by: - -
Published: (2008-03-01)

Problemy endokrinoterapii raka molochnoy zhelezy u muzhchin
by: E I Borisova, et al.
Published: (2009-03-01)

Second primary breast cancer after unilateral mastectomy alone or with contralateral prophylactic mastectomy
by: Shailesh Agarwal, et al.
Published: (2020-11-01)

Differences in physician opinions about controversial issues surrounding contralateral prophylactic mastectomy (CPM): A survey of physicians from accredited breast centers in the United States
by: Katharine Yao, et al.
Published: (2020-05-01)

Low grade serous carcinoma of the peritoneum in a BRCA1 carrier previously diagnosed with a “low-grade serous tubal intra-epithelial carcinoma” (STIC) on risk reducing surgery
by: Wen Yee Chay, et al.
Published: (2015-04-01)

Decision making in the surgical treatment of breast cancer: factors influencing women’s choices for mastectomy and breast conserving surgery
by: Emily Catherine Bellavance, et al.
Published: (2016-03-01)

ЦИТОРЕДУКТИВНАЯ МАСТЭКТОМИЯ В ЛЕЧЕНИИ ДЕСТРУКТИВНЫХ ФОРМ РАКА ГРУДНОЙ ЖЕЛЕЗЫ
by: A. M. Besedin, et al.
Published: (2017-07-01)

Prophylactic Mastectomy and Salpingo-Oophorectomy: Ethics and Policy
by: Majd T. Mrayyan, et al.
Published: (2020-01-01)

Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer
by: Akshara Singareeka Raghavendra, et al.
Published: (2021-04-01)

Лечение трижды негативного рака молочный железы у пациентки с метаболическим синдромом.
Published: (2021-03-01)

Predoperatsionnaya (neoad\"yuvantnaya) endokrinoterapiya postmenopauzal'nykh bol'nykh rakom molochnoy zhelezy
by: V F Semiglazov, et al.
Published: (2009-09-01)

Influence of ecological factors on dynamics of parameters of the hormonal status at an estimation of ways of deenergizing of function of ovaries at the patients, suffering a cancer of a mammary gland
by: S K Dzhubalieva, et al.
Published: (2009-06-01)

Contralateral risk-reducing local therapy in breast cancer patients with BRCA1/2 mutations: systemic review and meta-analysis
by: Ziqi Jia, et al.
Published: (2021-09-01)

The endometrium in women receiving adjuvant tamoxifen therapy after surgical treatment of breast cance
by: E V Dmitrieva, et al.
Published: (2013-12-01)

Concurrent hysterectomy and bilateral salpingo-oophorectomy during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for non-gynecologic cancers
by: McKayla J. Riggs, et al.
Published: (2020-08-01)

Press-release. «Sanofi» makes a contribution in improving availability of treatment in women with breast cancer in Russia in accordance with international standards
by: - -
Published: (2014-06-01)

Contralateral prophylactic mastectomy: current perspectives
by: Yao K, et al.
Published: (2016-06-01)

Epidemiologic aspects of breast cancer incidence in Baku
by: S S Vatankha
Published: (2018-04-01)

Prophylactic oophorectomy for hereditary small cell carcinoma of the ovary, hypercalcemic type
by: Andrew Berchuck, et al.
Published: (2015-04-01)

THE SINGLE-STAGE AND DELAYED RECONSTRUCTIVE PLASTY IN BREAST CANCER PATIENTS
by: Ye. M. Bit-Sava, et al.
Published: (2018-01-01)

РЕКОНСТРУКТИВНО-ПЛАСТИЧЕСКИЕ ОПЕРАЦИИ У БОЛЬНЫХ С BRCA1-АССОЦИИРОВАННЫМ РАКОМ МОЛОЧНОЙ ЖЕЛЕЗЫ
Published: (2018-01-01)

Fulvestrant v sovremennoy terapii rasprostranennogo raka molochnoy zhelezy: farmakoekonomicheskoe obosnovanie
by: V P Komarova, et al.
Published: (2007-09-01)

Kachestvo zhizni i simptomyu bol'nykh disseminirovannym gormonopozitivnym rakom molochnoy zhelezy v postmenopauze na fone primeneniya Fazlodeksa
by: A A Novik, et al.
Published: (2009-06-01)

Regional'naya programma lecheniya bol'nykh pervichno-generalizovannym i metastaticheskim rakom molochnoy zhelezy
by: - -
Published: (2007-09-01)

Ad\"yuvantnaya endokrinoterapiya postmenopauzal'nykh bol'nykh rakom molochnoy zhelezy
by: V F Semiglazov, et al.
Published: (2007-06-01)

Postmastektomicheskaya limfedema verkhnikh konechnostey: vozmozhnosti konservativnogo lecheniya
by: M O Myasnikova
Published: (2007-09-01)

HER-2-targetnaya terapiya raka molochnoy zhelezy: monoklonal'nye antitela i ingibitory tirozinkinazy
by: I N Ognerubova
Published: (2009-06-01)